arcadia

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE1345.20-27.1 (-1.97 %)
PREV CLOSE ( ) 1372.30
OPEN PRICE ( ) 1341.10
BID PRICE (QTY) 1344.05 (5)
OFFER PRICE (QTY) 1347.60 (3)
VOLUME 1151
TODAY'S LOW / HIGH ( )1339.00 1357.25
52 WK LOW / HIGH ( )1020 1812
NSE1342.00-29.55 (-2.15 %)
PREV CLOSE( ) 1371.55
OPEN PRICE ( ) 1365.00
BID PRICE (QTY) 1342.00 (6)
OFFER PRICE (QTY) 1342.95 (2)
VOLUME 6885
TODAY'S LOW / HIGH( ) 1332.00 1365.00
52 WK LOW / HIGH ( )1010 1800.05
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 13-11 1924
Management Info
D S Parekh - Chairman A Vaidheesh - Managing Director
Registered Office

Address Dr Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email askus@gsk.com

Website www.gsk-india.com

Registrars Details
Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
14Feb Glaxosmithkline Pharmaceuticals inform
Pursuant to Regulation 30(6) of the Schedule III, of the Listing Obligat..
07Feb Glaxosmithkline Pharmaceuticals inform
Glaxosmithkline Pharmaceuticals has informed about loss of share certifi..
07Feb Glaxosmithkline Pharmaceuticals inform
Pursuant to Clause 30 of the Listing Obligations and Disclosure Requirem..
04Feb GlaxoSmithKline Pharmaceuticals inform
GlaxoSmithKline Pharmaceuticals has informed about Loss of Share Certifi..
04Feb Glaxosmithkline Pharmaceuticals inform
Glaxosmithkline Pharmaceuticals has informed about a meeting of the Boar..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit1129.73519.8
Gross Profit 1697.8 5415.8
Operating Profit 1537.45619.6
Net Sales 8253.528958.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Ipca Laboratories (BSE)
 814.15 (5.05%)
M.Cap ( in Cr)10304.01
Alkem Laboratories (BSE)
 1837.90 (1.93%)
M.Cap ( in Cr)21980.83
Themis Medicare (BSE)
 315.75 (8.49%)
M.Cap ( in Cr)289.89
Piramal Enterprises (BSE)
 2176.00 (0.71%)
M.Cap ( in Cr)40212.78
Hester Biosciences (BSE)
 1388.00 (0.87%)
M.Cap ( in Cr)1182.45
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 12.52%
FI/BANKS/INSURANCE 8.2%
MUTUAL FUNDS/UTI 2.81%
FII 0%
GOVERNMENT 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM